XTalks

NOVEMBER 1, 2024

It is a biologic drug available exclusively as a brand-name medication, with no generic or biosimilar forms available. Botox is one of the most prescribed branded treatments for chronic migraine prevention, offering rapid relief with just four treatments per year. Price of Zolgensma: Zolgensma has a price of $2.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Viral Vectors for Gene Delivery to the CNS. Reporter genes to understand dose and distribution. Nusinersen: A Landmark Therapy.

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

FEBRUARY 22, 2021

This is particularly true in the case of cell and gene therapies, which could play a major part in improving future health care for our population.”. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. About Bayer. billion euros. Capital expenditures amounted to 2.9

Production 40

Production Vaccination Vaccine Gene Therapy 40

XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

The Pharma Data

MAY 31, 2022

The Company’s cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, immunology, and ophthalmology indications. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. For more information, visit www.bluerocktx.com.

Trials 52

Trials Engineer Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

Prior to SpringWorks, Smith was the executive vice president of Gene Therapy at Bamboo Therapeutics. Prior to joining Clarify, Gulati was a partner at McKinsey and Company, working with the Life Science, Medical Products and Health Systems practices in the US and EMEA. Rinri Therapeutics – Terri Gaskell was named CTO of U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

FEBRUARY 21, 2022

Bayer’s research and development pipeline continues to grow as the company is building on its existing competencies, such as the expertise around small molecules, while expanding into new modalities, including cell and gene therapies. The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.

Radiology 52

Radiology Cardiology Development Production 52

The Pharma Data

APRIL 11, 2023

Another key focus at Bayer is on innovative precision oncology treatments, with an approved TRK inhibitor exclusively designed to treat tumors that have an NTRK gene fusion, the oncogenic driver of tumor growth and spread. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

Research 40

Research Clinical Trials Clinical Trials Trials 40

pharmaphorum

FEBRUARY 16, 2022

Will all the efforts to speed up market access and ensure that the UK remains attractive to the life sciences industry post-Brexit pay off in 2022? Novartis’ gene therapy Zolgensma (onasemnogene abeparvovec-xioi) for SMA. Life Sciences Vision set an ambitious agenda in 2021 with delivery ongoing in 2022.

Marketing 52

Marketing Life Science Medicine Gene Therapy 52

Drug Channels

OCTOBER 19, 2020

16th Annual Life Sciences Trade and Channel Strategies. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Get ready to hit the ground running in 2021 by closing out the year at Trade and Channel 2020 ! Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs.

Life Science 52

Life Science Pharmacy Gene Therapy Gene 52

Drug Channels

NOVEMBER 8, 2020

16th Annual Life Sciences Trade and Channel Strategies. That’s why the life science industry’s top experts will come together virtually on December 1-3 at Trade and Channel 2020. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Life Science 52

Life Science Pharmacy Gene Therapy Drugs 52

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. Alecensa is approved in Japan for the additional indication of recurrent or refractory ALK fusion gene-positive anaplastic large-cell lymphoma.

FDA Approval 101

FDA Approval Drugs Sales Development 101

pharmaphorum

NOVEMBER 16, 2021

Any new commitments on measuring uptake should be aligned with the broader agenda, such as that set out in the Life Sciences Vision and focus on innovation by measuring uptake of medicines seen as innovative. Time and budget will affect just how many. Go further and deliver on investigating the reasons for uptake being high or low.

Medicine 96

Medicine Branding Gene Therapy Life Science 96

The Pharma Data

MARCH 11, 2021

Speaking at the virtual Capital Markets Day on Wednesday, CEO Werner Baumann emphasized Bayer’s long-term growth perspectives: “Bayer is a leading life science company, uniquely positioned at the intersection of health and nutrition – with attractive prospects for growth, earnings and cash flow.”

Sales 52

Sales Gene Therapy Marketing Gene 52

The Pharma Data

MARCH 16, 2022

Marieke Oudelaar (Max Planck Institute for Biophysical Chemistry in Göttingen) for her outstanding contributions in the development of methods to characterize the 3D structure of the genome and her work on the interaction between gene-regulatory elements at specific gene loci. Dr. Connor W. billion euros. billion euros.

Protein 52

Protein Scientist Gene Development 52

XTalks

FEBRUARY 16, 2024

Originally developed by California-based CoTherix, the drug was first approved in 2004 for the treatment of pulmonary arterial hypertension (PAH) under the brand name Ventavis. More often than not, severe frostbite leads to the need for amputation. At the time, it was the only inhaled therapy for PAH in the US. of 100,000 people.

Cardiology 59

Cardiology Gene Therapy Drugs Branding 59

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. Alecensa is approved in Japan for the additional indication of recurrent or refractory ALK fusion gene-positive anaplastic large-cell lymphoma.

FDA Approval 52

FDA Approval Drugs Sales Development 52

XTalks

APRIL 11, 2024

2seventy has been used to the struggles ever since it spun out of gene therapy biotech bluebird bio. On the other hand, Abecma is now approved as a third-line treatment for patients with triple-class-exposed disease, which means previous treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 monoclonal antibody.

FDA Approval 52

FDA Approval Manufacturing Trials Clinical Trials 52

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

FEBRUARY 21, 2025

BioRad Laboratories Life science research and diagnostics giant BioRad announced a 5% workforce reduction over 350 employees with the most significant cuts at its Hercules headquarters, along with additional layoffs at its Pleasanton and Richmond locations. The layoffs primarily impact roles in technology and early-stage R&D.

Life Science 66

Life Science Marketing Gene Therapy Research 66

The Pharma Data

MAY 15, 2023

Access to local NGS testing can help to provide faster analysis of genes associated, empowering healthcare providers to select the right therapy for that individual patient. Single gene testing has historically been used to match patients with appropriate targeted therapies. About Thermo Fisher Scientific Thermo Fisher Scientific Inc.

Marketing 40

Marketing Genome Genomics Gene 40

XTalks

MAY 2, 2024

Among these are Madrigal Pharmaceuticals’ resmetirom (branded Rezdiffra) , which secured FDA approval in March for the treatment of nonalcoholic steatohepatitis (NASH) and sotatercept (commercial name Winrevair) for pulmonary hypertension (PAH). Since January, the FDA has already signed off on more than a dozen novel drugs.

Drugs 52

Drugs FDA Approval Vaccination Vaccine 52

XTalks

SEPTEMBER 14, 2020

For example, Tailored Brands, the parent of Men’s Wearhouse and K & G, have declared they may have to file for bankruptcy protection, joining almost 7,000 other companies that filed for Chapter 11 bankruptcy protection last year. Meanwhile, the Congressional Budget office predicted that the US economy would expand at an annual rate of 12.4

Vaccination 92

Vaccination Vaccine Antibody Life Science 92